All News

Cardiovascular disease (CVD) remains the leading cause of morbidity for women in the United States. Prior to the update in 2020, published in the Journal of the American College of Cardiology, there had been no formal guidelines from the American College of Cardiology (ACC)/American Heart Association (AHA) specifically addressing CVD in women since 2011.

Many women gain weight during menopause. Aging and lifestyle are the main factors, and women generally become less active as they go through midlife. At any age, it is known that burning fewer calories increases weight and fat mass. But what can providers do?

“Don’t it always seem to go, that you don’t know what you’ve got ‘til it’s gone.” Samar R. El Khoudary, PhD, MPH, used Joni Mitchell’s popular song lyrics to introduce the crowd to her session, “Health is Where the Heart Is,” which addressed the connection between heart health and menopause.

Holly Wyatt, MD’s session, "The Tao of Wellness," kicked off the North American Menopause Society’s (NAMS) 2021 Annual Meeting. It was the springboard for the Utian Translational Science Symposium, themed “Charting the Path to Health in Midlife and Beyond: The Biology and Practice of Wellness.”

This week, Contemporary OB/GYN® will be covering the North American Menopause Society’s (NAMS) 2021 Annual Meeting, which is taking place Sept. 22-25 in Washington, D.C. We spoke with NAMS President Hadine Joffe, MD, MSc about wellness at midlife and why it is crucial in menopause.

In this protocol, Ramsey reviews the health implications of obesity for mother and fetus. The incidence of obesity in the United States has increased dramatically. Of pregnant women in the country, more than half are overweight or obese and 8% or more are extremely obese. As the author notes, excessive gestational weight gain, particularly in women who are already overweight or obese, increases risk of maternal complications such as diabetes, hypertension, and operative deliveries and neonatal outcomes such as macrosomia and stillbirth.

Among women with opioid use disorder (OUD) at high risk for unintended pregnancy, on-site contraceptive services coupled with financial incentives to attend follow-up visits to assess contraceptive satisfaction was a significantly more effective and cost-beneficial intervention than without incentives or with usual care, according to a prospective randomized clinical trial in JAMA Psychiatry.

"Over the last few months, my personal barometer of success as a physician seems to be directly related to my patients' acceptance--or refusal--of the COVID-19 vaccine," writes Rebekah Bernard, MD.